Cargando…

Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers

BACKGROUND: For evidence-based medical practice, well-defined risk scoring systems are essential to identify patients with a poor prognosis. The objective of this study was to develop a prognostic score, the Montreal prognostic score (MPS), to improve prognostication of patients with incurable non-s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gagnon, B, Agulnik, J S, Gioulbasanis, I, Kasymjanova, G, Morris, D, MacDonald, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798950/ https://www.ncbi.nlm.nih.gov/pubmed/24064979 http://dx.doi.org/10.1038/bjc.2013.515

Ejemplares similares

Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer
por: Gagnon, B, et al.
Publicado: (2010)

Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients
por: Cho, Anna, et al.
Publicado: (2020)

Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)
por: Vernerey, Dewi, et al.
Publicado: (2016)

Completely Resected N0 Non-Small Cell Lung Cancer: Prognostic Factors Affecting Long-Term Survival
por: Tantraworasin, Apichat, et al.
Publicado: (2013)

Comparison of the montreal cognitive assessment and the mini-mental state examination as screening tests in hemodialysis patients without symptoms
por: Lee, Sun Hwa, et al.
Publicado: (2018)

A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index
por: Colinet, B, et al.
Publicado: (2005)

The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
por: Akazawa, Yuki, et al.
Publicado: (2023)

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer
por: Crumley, A B C, et al.
Publicado: (2006)

Real-World Pattern of Treatment and Clinical Outcomes of EGFR-Mutant Non-Small Cell Lung Cancer in a Single Academic Centre in Quebec
por: Agulnik, Jason S., et al.
Publicado: (2021)

Prognostic and Survival Factors in Myxofibrosarcomas
por: Dewan, Varun, et al.
Publicado: (2012)

Towards Improved Prognostic Scores Predicting Survival in Patients with Brain Metastases: A Pilot Study of Serum Lactate Dehydrogenase Levels
por: Nieder, Carsten, et al.
Publicado: (2012)

Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer
por: Jiang, X, et al.
Publicado: (2012)

Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK
por: Campbell, H E, et al.
Publicado: (2010)

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results
por: Mascaux, C, et al.
Publicado: (2006)

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
por: Pinato, D J, et al.
Publicado: (2014)

Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems
por: Lamb, G W A, et al.
Publicado: (2012)

Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit
por: Khakwani, A, et al.
Publicado: (2013)

Innovative estimation of survival using log-normal survival modelling on ACCENT database
por: Chapman, J W, et al.
Publicado: (2013)

Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
por: Agulnik, Jason S., et al.
Publicado: (2022)

The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
por: Kang, M H, et al.
Publicado: (2014)

Development of a Score Predicting Survival after Palliative Reirradiation
por: Nieder, Carsten, et al.
Publicado: (2014)

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients
por: Troppan, K T, et al.
Publicado: (2014)

Assessing the Performance of Prognostic Scores in Patients with Spinal Metastases from Lung Cancer Undergoing Non-surgical Treatment
por: Truong, Van Tri, et al.
Publicado: (2023)

Surgical resection of brain metastases: the prognostic value of the graded prognostic assessment score
por: Jakola, A. S., et al.
Publicado: (2011)

Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma
por: Toh, C-K, et al.
Publicado: (2005)

Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients
por: Lv, Yongbin, et al.
Publicado: (2017)

Baseline tumour measurements predict survival in advanced non-small cell lung cancer
por: Gerber, D E, et al.
Publicado: (2013)

Prognostic value of a patient-reported functional score versus physician-reported Karnofsky Performance Status Score in brain metastases
por: Agarwal, Jai Prakash, et al.
Publicado: (2017)

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer
por: Murri, A M Al, et al.
Publicado: (2006)

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study
por: Elhassan, Y S, et al.
Publicado: (2021)

Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival
por: Nisman, B, et al.
Publicado: (2008)

Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial
por: Ediebah, D E, et al.
Publicado: (2014)

Metastatic melanoma: prognostic factors and survival in patients with brain metastases
por: Frinton, E., et al.
Publicado: (2017)

Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection
por: Parnaby, C N, et al.
Publicado: (2015)

The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review
por: Kasymjanova, Goulnar, et al.
Publicado: (2021)

Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer
por: Roxburgh, C S D, et al.
Publicado: (2009)

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
por: Bertorelle, R, et al.
Publicado: (2013)

Montreal
por: Dell, Harry H.
Publicado: (1896)

Montreal
por: McGregor, James
Publicado: (1899)

Estimating progression-free survival in patients with glioblastoma using routinely collected data
por: Kelly, Charlotte, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4geh94ibhpb89jqo7qe5pdogmm